Clinical trial
Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With…
NCT00040417 · Baylor College of Medicine, Other · Terminated
Key facts
| NCT number | NCT00040417 |
|---|---|
| Title | Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies |
| Official title | Allo SCT From HLA Haploidentical Related Donors Using Sub-Myeloablative Conditioning For Patients With High Risk Hemoglobinopathies: Hemo SS, Hemo SC, Hemo SB0/+ Thalassemia, Homozygous B0/+ Thalassemia or Severe B0/+ Thalassemia Variants |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | The Methodist Hospital Research Institute |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sickle Cell Anemia, Hemoglobinopathy, Thalassemia |
| Intervention type | Drug, Procedure |
| Interventions | FLUDARABINE, CAMPATH-IH, Total Body Irradiation, FK506, G-SCF (Granulocyte-colony stimulating factor) |
| Enrollment | 15 |
| Start date | Aug 1, 2000 |
| Primary completion | Nov 21, 2003 |
| Completion | Nov 21, 2003 |
| First posted | Jun 27, 2002 |
| Last update posted | Jan 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: